NVCR - Novocure Ltd - SEC Form 4 Insider Trading Screener

Manufactured Goods - Specialty Instruments - Surgical & Medical Instruments & Apparatus - NVCR (1645113)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
59 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-11-07
NVCRShah PriteshChief Growth OfficerS - Sale$12.65-382124,5110%-$4,832
2023-09-01
NVCRCordova AshleyCFOS - Sale$21.82-88399,650-1%-$19,265
2023-09-01
NVCRGroenhuysen Wilhelmus CmCOOS - Sale$21.82-294209,8250%-$6,414
2023-09-01
NVCRShah PriteshChief Growth OfficerS - Sale$21.82-273124,8930%-$5,956
2023-08-02
NVCRCordova AshleyCFOS - Sale$30.25-1,144100,533-1%-$34,607
M
2023-03-03
NVCRLeonard Frank XPres, CNS Cancers USS - Sale$75.55-13,60954,284-20%-$1,028,165
2023-03-03
NVCRShah PriteshChief Growth OfficerS - Sale$76.16-21,421124,799-15%-$1,631,411
2023-03-03
NVCRGroenhuysen Wilhelmus CmCOOS - Sale$76.16-25,635209,753-11%-$1,952,346
2023-03-03
NVCRCordova AshleyCFOS - Sale$76.16-5,505101,310-5%-$419,257
2023-03-03
NVCRBurke William PatrickCHROS - Sale$76.16-59366,090-1%-$45,163
2023-03-02
NVCRBurke William PatrickCHROS - Sale$75.28-28166,6830%-$21,153
2023-03-02
NVCRShah PriteshChief Growth OfficerS - Sale$75.28-937146,220-1%-$70,535
2023-03-02
NVCRGroenhuysen Wilhelmus CmCOOS - Sale$75.28-1,213235,388-1%-$91,312
2023-03-02
NVCRCordova AshleyCFOS - Sale$75.28-1,055106,815-1%-$79,418
M
2023-03-02
NVCRLeonard Frank XPres, CNS Cancers USS - Sale$76.95-2,90367,893-4%-$223,393
2023-03-02
NVCRLeonard Frank XPres, CNS Cancers USS - Sale$75.38-4,10758,988-7%-$309,578
D
2023-03-01
NVCRLeonard Frank XPres, CNS Cancers USS - Sale+OE$76.36-1,68463,095-3%-$128,594
D
2023-03-01
NVCRShah PriteshChief Growth OfficerS - Sale+OE$76.36-1,92399,975-2%-$146,845
D
2023-03-01
NVCRCordova AshleyCFOS - Sale+OE$76.36-2,19896,062-2%-$167,845
D
2023-03-01
NVCRBurke William PatrickCHROS - Sale+OE$76.36-75566,964-1%-$57,654
D
2023-03-01
NVCRGroenhuysen Wilhelmus CmCOOS - Sale+OE$76.36-2,164184,615-1%-$165,248
D
2023-01-05
NVCRWeinberg UriChief Science OfficerS - Sale+OE$116.14-8,14343,286-16%-$945,756
D
2023-01-05
NVCRLeonard Frank XPres, CNS Cancers USS - Sale+OE$112.25-39,50746,158-46%-$4,434,654
2023-01-05
NVCRShah PriteshChief Commercial OfficerS - Sale$108.00-38782,8430%-$41,796
D
2023-01-05
NVCRDanziger AsafCEOS - Sale+OE$108.74-212,50013,622-94%-$23,106,230
2022-10-13
NVCRLeonard Frank XPres, CNS Cancers USS - Sale$76.01-6,75443,626-13%-$513,372
2022-10-06
NVCRLeonard Frank XPres, CNS Cancers USS - Sale$84.37-6,75450,380-12%-$569,835
2022-09-29
NVCRLeonard Frank XPres, CNS Cancers USS - Sale$77.35-6,75457,134-11%-$522,422
2022-09-22
NVCRLeonard Frank XPres, CNS Cancers USS - Sale$77.00-6,75463,888-10%-$520,058
D
2022-09-15
NVCRLeonard Frank XChief Development OfficerS - Sale+OE$88.52-12,27170,642-15%-$1,086,222
A
2022-09-08
NVCRLeonard Frank XChief Development OfficerS - Sale$81.48-6,75477,396-8%-$550,316
2022-09-09
NVCRLeonard Frank XChief Development OfficerS - Sale$88.00-1,86384,150-2%-$163,944
2022-09-06
NVCRLeonard Frank XChief Development OfficerS - Sale$78.57-1,38486,013-2%-$108,741
2022-09-02
NVCRBurke William PatrickCHROS - Sale$79.04-71855,486-1%-$56,749
2022-09-02
NVCRCordova AshleyCFOS - Sale$79.04-88572,376-1%-$69,948
2022-09-02
NVCRGroenhuysen Wilhelmus CmCOOS - Sale$79.04-296165,0240%-$23,395
2022-09-02
NVCRShah PriteshChief Commercial OfficerS - Sale$79.04-26983,2300%-$21,261
M
2022-09-01
NVCRLeonard Frank XChief Development OfficerS - Sale$77.50-14,79687,397-14%-$1,146,634
2022-08-03
NVCRBenaim ElyChief Medical OfficerS - Sale$73.73-5,95928,672-17%-$439,328
2022-08-02
NVCRDoyle William FExec COBS - Sale$69.66-837551,1760%-$58,305
2022-08-02
NVCRBenaim ElyChief Medical OfficerS - Sale$69.66-43734,631-1%-$30,441
2022-08-02
NVCRLeonard Frank XChief Development OfficerS - Sale$69.66-414102,1930%-$28,839
2022-06-10
NVCRHilleman Jeryl LDirS - Sale$69.61-4072,537-14%-$28,331
M
2022-05-10
NVCRBenaim ElyChief Medical OfficerS - Sale$63.17-4,20534,846-11%-$265,646
D
2022-03-09
NVCRShah PriteshChief Commercial OfficerS - Sale+OE$71.19-3,66983,187-4%-$261,196
M
2022-03-07
NVCRShah PriteshChief Commercial OfficerS - Sale$69.73-7,77581,908-9%-$542,116
2022-03-08
NVCRLeonard Frank XChief Development OfficerS - Sale$70.10-744102,295-1%-$52,154
2022-03-08
NVCRBurke William PatrickCHROS - Sale$70.10-1,03755,991-2%-$72,694
2022-03-08
NVCRGroenhuysen Wilhelmus CmCOOS - Sale$70.10-2,923165,102-2%-$204,902
2022-03-08
NVCRCordova AshleyCFOS - Sale$70.10-75960,848-1%-$53,206
2022-03-08
NVCRLongsworth Todd ChristopherGCS - Sale$70.10-2,33962,462-4%-$163,964
2022-03-08
NVCRDoyle William FExec COBS - Sale$70.10-2,385552,0130%-$167,189
DM
2022-03-03
NVCRLongsworth Todd ChristopherGCS - Sale+OE$71.87-3,06764,801-5%-$220,414
DM
2022-03-03
NVCRCordova AshleyCFOS - Sale+OE$73.16-1,70561,607-3%-$124,744
DM
2022-03-03
NVCRShah PriteshChief Commercial OfficerS - Sale+OE$72.54-5,54389,683-6%-$402,064
DM
2022-03-03
NVCRBenaim ElyChief Medical OfficerS - Sale+OE$71.83-2,31343,257-5%-$166,136
DM
2022-03-03
NVCRBurke William PatrickCHROS - Sale+OE$71.43-1,36757,028-2%-$97,641
DM
2022-03-03
NVCRGroenhuysen Wilhelmus CmCOOS - Sale+OE$71.78-3,870168,025-2%-$277,797
DM
2022-03-03
NVCRLeonard Frank XChief Development OfficerS - Sale+OE$72.97-1,485103,039-1%-$108,359

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top